Sen. Martin Heinrich

Maddy summaryS 803, the Keep Americans Safe Act, prohibits the import, sale, manufacture, transfer, or possession of large capacity ammunition feeding devices (devices holding more than 10 rounds, excluding specific .22 caliber tubular devices) in interstate or foreign commerce. It directly affects the general public, while exempting law enforcement officers (including campus police), retired officers with agency-issued devices, nuclear security personnel, and manufacturers testing under federal authorization. Key provisions include requiring serial numbers on new devices, expanding forfeiture for violations, and allowing federal Byrne grants to fund buy-back programs for surrendered devices. The bill takes effect upon enactment, with existing devices lawfully owned before enactment remaining legal.

Maddy summarySJRES 10, introduced by Senators Kaine and Heinrich, would terminate the national emergency related to energy declared by the President on January 20, 2025, under Executive Order 14156. This resolution ends the emergency as authorized by the National Emergencies Act, removing the special legal authorities granted during the emergency period. Upon passage, federal agencies would no longer operate under the emergency framework for energy-related policies, reverting to standard regulatory processes.

This resolution recognizes Black History Month as an opportunity to reflect on U.S. history and to commemorate the contributions of African Americans. It calls for the United States to (1) honor the contribution of pioneers who helped to ensure its legacy; and (2) move forward as a nation "indivisible, with liberty and justice for all."

Maddy summaryThis resolution expresses the Senate's disapproval of the U.S. delegation's February 24, 2025, vote at the United Nations General Assembly against a Ukraine peace resolution (A/ES-11/L.10). It condemns the vote as the first U.S. alignment with Russia on Ukraine since 2014, criticizing the refusal to identify Russia as an aggressor or demand its withdrawal from Ukraine. The resolution has no binding effect but formally urges future UN cooperation with Ukraine and allies while reaffirming support for Ukraine's sovereignty.

Maddy summaryThis bill creates a streamlined process for out-of-state healthcare providers to enroll in Medicaid or CHIP (Children's Health Insurance Program) in a state. It directly affects children under 21 enrolled in these programs and healthcare providers located in other states who already meet low fraud risk standards. The key provision requires states to adopt a simplified enrollment process using only basic provider information (like name and National Provider Identifier), granting eligible providers a 5-year enrollment period without repeated screening. This reduces administrative barriers for providers serving out-of-state children under 21 who qualify for Medicaid or CHIP coverage.

Maddy summaryThis resolution (SRES 93) expresses the Senate's view that the National Institutes of Health (NIH) should not face funding disruptions or operational delays that violate existing law. It specifically highlights the importance of uninterrupted NIH work on research for diseases like cancer, Alzheimer’s, diabetes, and heart disease. The resolution emphasizes that NIH scientists and researchers are essential to medical progress and public health efforts. As a symbolic resolution, it does not change funding laws or create new policies - it solely states the Senate’s position on protecting NIH operations.

Maddy summaryThis bill establishes a mandatory $150 million funding stream (2025-2029) from the Commodity Credit Corporation to improve public access to conservation lands. It specifically allocates $3 million to encourage public access to wetland reserve easement lands through agreements with states and tribal governments. The program directly affects landowners holding these easements and state/tribal entities managing conservation areas. The key mechanism is using federal funds to incentivize voluntary agreements that make existing wetland conservation areas more accessible to the public.

Maddy summaryS 703 (CATCH Fentanyl Act) establishes pilot projects at U.S. border ports to test non-intrusive inspection technologies - such as AI, machine learning, and quantum sensing - to improve detection of contraband, drugs, and threats in cargo and vehicles. The bill requires testing at least five technology types from specified categories, prioritizing those that enhance detection accuracy, reduce wait times, integrate with existing systems, and demonstrate cost-effectiveness. It mandates reports analyzing pilot results, privacy safeguards for data collected during inspections, and recommendations for nationwide implementation, with no new funding authorized. The legislation directly affects U.S. Customs and Border Protection (CBP) at land border ports and aims to modernize inspection processes without altering existing legal frameworks.

Maddy summaryS 697 establishes the Air Traffic Control Workforce Development Act of 2025 to strengthen training and retention for air traffic controllers. It creates a $20 million annual grant program (2026-2031) for colleges to develop enhanced curriculum, faculty support, and equipment for the Collegiate Training Initiative (CTI), directly benefiting institutions and future controllers. The bill also mandates a committee to modernize CTI curricula and the Air Traffic Skills Assessment exam, while adding retention bonuses for certified controllers. Additionally, it requires new mental health training for controllers and aviation medical examiners, and a report on airport radar systems. These changes aim to improve workforce pipeline efficiency and controller well-being.

Maddy summaryS 526, the Pharmacy Benefit Manager Transparency Act of 2025, requires pharmacy benefit managers (PBMs) - the middlemen managing drug coverage for health plans - to disclose financial details and stop unfair practices. It prohibits PBMs from keeping price differences between what they charge health plans and pay pharmacies, arbitrarily clawing back payments, or inflating fees to offset government-mandated changes. PBMs must annually report to the FTC and HHS on rebate sharing, fee structures, formulary changes, and reimbursement differences, including whether drug tier shifts were influenced by manufacturers. This directly affects PBMs, pharmacies, health plans, and patients by increasing transparency in drug pricing and reimbursement.